Fmoc-L-cysteic acid . disodium salt |
| Catalog No.GA21706 |
Protected derivative for the introduction of this highly polar amino acid. Cya-containing peptides are obtained by oxidation of cysteine or cystine, as a post-translational modification, as a by-product during peptide synthesis, or, intentionally (by using oxidants as H?O?/formic acid), for quantification of these sensitive amino acids. Use of B-4030 allows to obtain Cya-peptides containing sensitive amino acids, as an additional oxidation step is not required.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 320384-09-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Protected derivative for the introduction of this highly polar amino acid. Cya-containing peptides are obtained by oxidation of cysteine or cystine, as a post-translational modification, as a by-product during peptide synthesis, or, intentionally (by u
Average Rating: 5 (Based on Reviews and 9 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *